Advertisement

Picture AB Sciex Berliner LCMSMS Symposium 2017 Middle 600x60px
Organisation › Details

4SC (Group)

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various cancer and autoimmune indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies. Founded in 1997, 4SC had a headcount of 66 employees (57 FTEs) at 31 December 2014. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005. *

 

Period Start 1997-01-01 established
Period End  renamed
Products Industry BIOTECH
  Industry 2 resminostat (4SC-201)
Persons Person Spillner, Enno (Evotec 201607– CFO before 4SC CEO + CFO before BioM Venture Capital GmbH)
  Person 2 Dauer, Ulrich (Omeicos 2010504– Managing Director (CEO) before Activaero + 4SC + Tripos)
     
Region Region Martinsried
  Country Germany
  Street 19a Am Klopferspitz
  City 82152 Martinsried
  Tel +49-89-700763-0
  Fax +49-89-700763-29
    Address record changed: 2012-01-19
     
Basic data Employees C: 51 to 100 (2015-12-31)
  Currency EUR
  Annual sales 3,266,000 (revenue, consolidated (2015) 2015-12-31)
  Profit -9,228,000 (2015-12-31)
  Cash 21,476,000 (2014-12-31)
     
    * Document for »About Section«: 4SC AG. (3/25/15). "Press Release: 4SC Publishes Results for Financial Year 2014". Planegg-Martinsried.
     
   
Record changed: 2016-04-30

Advertisement

Picture EBD Group Biotech Showcase 2017 BTS San Francisco January 600x60px

More documents for 4SC (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Bruker NMR The Future of IVD In Vitro Diagnostics LSG Middle 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture Bruker NMR IVDr LSG Right 120x180px Picture EBD Group Biotech Showcase 2017 BTS San Francisco January 600x60px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Bruker NMR IVDr LSG Right 120x180px